These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7615696)

  • 21. Molecular analysis of p53 and K-ras in lung carcinomas of coal miners.
    Sarkar FH; Li Y; Vallyathan V
    Int J Mol Med; 2001 Oct; 8(4):453-9. PubMed ID: 11562787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coalterations of p53 and PTEN tumor suppressor genes in non-small cell lung carcinoma patients.
    Andjelkovic T; Bankovic J; Stojsic J; Milinkovic V; Podolski-Renic A; Ruzdijic S; Tanic N
    Transl Res; 2011 Jan; 157(1):19-28. PubMed ID: 21146147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.
    Ludovini V; Pistola L; Gregorc V; Floriani I; Rulli E; Piattoni S; Di Carlo L; Semeraro A; Darwish S; Tofanetti FR; Stocchi L; Mihaylova Z; Bellezza G; Del Sordo R; Daddi G; Crinò L; Tonato M
    J Thorac Oncol; 2008 Apr; 3(4):365-73. PubMed ID: 18379354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis.
    Kawasaki H; Ogura T; Yokose T; Nagai K; Nishiwaki Y; Esumi H
    Hum Pathol; 2001 Oct; 32(10):1043-9. PubMed ID: 11679937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonality analysis of different histological components in combined small cell and non-small cell carcinoma of the lung.
    Murase T; Takino H; Shimizu S; Inagaki H; Tateyama H; Takahashi E; Matsuda H; Eimoto T
    Hum Pathol; 2003 Nov; 34(11):1178-84. PubMed ID: 14652820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlation between RARbeta gene promoter methylation and P53 gene mutations in non-small cell lung cancer].
    Tan C; Jin YT; Xu HY; Zhang CY; Zhang H; Zhang WM; Chen CM; Sun XY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):131-6. PubMed ID: 22487818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carcinogen exposure, p53 alteration, and K-ras mutation in synchronous multiple primary lung carcinoma.
    Wang X; Christiani DC; Mark EJ; Nelson H; Wiencke JK; Gunn L; Wain JC; Kelsey KT
    Cancer; 1999 Apr; 85(8):1734-9. PubMed ID: 10223567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer.
    Chang MY; Chong IW; Chen FM; Wang JY; Cheng TL; Cheng YJ; Sheu CC; Hung SY; Yang MC; Lin SR
    Cancer Lett; 2005 May; 222(2):195-204. PubMed ID: 15863268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis of mutation types of p53 gene and possible carcinogenic factors in lung cancer].
    Gao ZQ; Gao Z; Zhang X
    Zhonghua Yu Fang Yi Xue Za Zhi; 1997 Mar; 31(2):88-91. PubMed ID: 9812619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of the p53 and K-ras gene mutation patterns for cytologic diagnosis of recurrent lung carcinomas.
    Dai Y; Morishita Y; Mase K; Sato N; Akaogi E; Mitsui T; Noguchi M
    Cancer; 2000 Aug; 90(4):258-63. PubMed ID: 10966568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma.
    Navone NM; Troncoso P; Pisters LL; Goodrow TL; Palmer JL; Nichols WW; von Eschenbach AC; Conti CJ
    J Natl Cancer Inst; 1993 Oct; 85(20):1657-69. PubMed ID: 7692074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequent TP53 gene alterations (mutation, allelic loss, nuclear accumulation) in primary non-small cell lung cancer.
    Shipman R; Schraml P; Colombi M; Raefle G; Dalquen P; Ludwig C
    Eur J Cancer; 1996 Feb; 32A(2):335-41. PubMed ID: 8664051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment.
    Marchetti A; Martella C; Felicioni L; Barassi F; Salvatore S; Chella A; Camplese PP; Iarussi T; Mucilli F; Mezzetti A; Cuccurullo F; Sacco R; Buttitta F
    J Clin Oncol; 2005 Feb; 23(4):857-65. PubMed ID: 15681531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increase in the frequency of p16INK4 gene inactivation by hypermethylation in lung cancer during the process of metastasis and its relation to the status of p53.
    Seike M; Gemma A; Hosoya Y; Hemmi S; Taniguchi Y; Fukuda Y; Yamanaka N; Kudoh S
    Clin Cancer Res; 2000 Nov; 6(11):4307-13. PubMed ID: 11106248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of SOX4 gene mutation in non-small cell lung cancer tissues.
    Chen QL; Zheng WL; Yao WJ; Nie LW; Cheng SH; Ma WL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):505-9. PubMed ID: 17922414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survivin gene expression is negatively regulated by the p53 tumor suppressor gene in non-small cell lung cancer.
    Nakano J; Huang CL; Liu D; Ueno M; Sumitomo S; Yokomise H
    Int J Oncol; 2005 Nov; 27(5):1215-21. PubMed ID: 16211215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of inactivation of CDKN2 and MTS2 in non-small cell lung cancer and association with advanced stage.
    Nakagawa K; Conrad NK; Williams JP; Johnson BE; Kelley MJ
    Oncogene; 1995 Nov; 11(9):1843-51. PubMed ID: 7478613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Detection of the p53 protein accumulation and p53 gene mutation in squamous cell carcinoma of the lung].
    Li S; Liu H; Wang D
    Zhonghua Bing Li Xue Za Zhi; 1998 Apr; 27(2):123-6. PubMed ID: 11244963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A dose-response relationship between the frequency of p53 mutations and tobacco consumption in lung cancer patients.
    Kondo K; Tsuzuki H; Sasa M; Sumitomo M; Uyama T; Monden Y
    J Surg Oncol; 1996 Jan; 61(1):20-6. PubMed ID: 8544455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of mutations and a germ line polymorphism of the p53 gene in non-small cell lung carcinoma: association with clinicopathological features.
    Tagawa M; Murata M; Kimura H
    Cancer Lett; 1998 Jun; 128(1):93-9. PubMed ID: 9652798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.